Since the first stock market in Amsterdam in the 17th century, trading floors have been dominated by men. It turns out testosterone may be responsible for some of the dramatic bubbles and crashes we have seen since.
Aug 16, 2017
0
0
Chinese health officials gave no indication Saturday of any relaxation of COVID-19 restrictions, following several days of speculation that the government was considering changes to a "zero-COVID" approach that has stymied ...
Nov 6, 2022
0
8
As much of Europe is engulfed by a second wave of COVID-19, and track and trace struggles to meet demand, modeling support tools are being increasingly used by policymakers to make key decisions. Most notably, models have ...
Oct 23, 2020
0
2
South Korea reported its biggest surge in new coronavirus cases on Saturday as concerns grew of a possible epidemic in the United States and the World Health Organization raised its risk alert to its highest level.
Feb 29, 2020
0
2
Billions of neurons fire in the brains of stock market traders as they decide whether to buy or sell shares in a matter of seconds. Some of these brain waves produce rational calculations about how best to make a profit, ...
Jul 11, 2014
0
0
You've heard of Big Pharma and Big Tobacco. How about Big Marijuana?
Nov 14, 2018
0
0
Neuroscientists have uncovered a key brain area in rats that encodes the value of economic choices when faced with the uncertainty of a lottery. This is the first time the causal role of frontal and parietal cortex has been ...
Oct 19, 2023
0
17
Falling stock prices lead to increased hospitalisations for mental disorders, according to new research published today in the journal Health Policy and Planning.
Feb 13, 2014
0
0
Suppose you had $1,000 to invest in the stock market. How would you decide to pick one stock over another? Scientists have made great progress in understanding the neuroscience behind how people choose between similar options.
Apr 19, 2013
0
0
India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.
Mar 13, 2012
0
0
